Corcept Therapeutics
(CORT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 125,138 | 102,745 | 89,819 | 127,665 | 137,289 |
| Marketable Securities | 296,545 | 239,481 | 232,944 | 255,669 | 243,047 |
| Receivables | 69,629 | 64,567 | 61,819 | 53,976 | 59,717 |
| Inventories | 12,349 | 12,276 | 14,368 | 12,412 | 8,050 |
| TOTAL | $541,130 | $443,112 | $438,503 | $471,602 | $466,978 |
| Non-Current Assets | |||||
| PPE Net | 2,094 | 2,348 | 2,543 | 2,689 | 2,930 |
| Investments And Advances | 102,557 | 172,775 | 248,041 | 219,831 | 167,310 |
| Other Non-Current Assets | 177,826 | 183,487 | 157,368 | 146,431 | 147,039 |
| TOTAL | $282,477 | $358,610 | $407,952 | $368,951 | $317,279 |
| Total Assets | $823,607 | $801,722 | $846,455 | $840,553 | $784,257 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 34,446 | 23,525 | 27,947 | 15,376 | 18,584 |
| Accrued Expenses | 28,322 | 29,049 | 25,260 | 33,868 | 27,736 |
| TOTAL | $172,265 | $144,664 | $143,066 | $140,773 | $126,216 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 5,588 | 5,851 | 0 | 0 |
| TOTAL | $19,440 | $21,265 | $20,104 | $20,191 | $19,206 |
| Total Liabilities | $191,705 | $165,929 | $163,170 | $160,964 | $145,422 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 105,188 | 105,372 | 106,045 | 105,503 | 104,775 |
| Common Shares | 139 | 138 | 137 | 136 | 135 |
| Retained earnings | 619,099 | 599,431 | 564,282 | 543,735 | 512,989 |
| Other shareholders' equity | 2,051 | 2,360 | 1,000 | -390 | 1,394 |
| TOTAL | $631,902 | $635,793 | $683,285 | $679,589 | $638,835 |
| Total Liabilities And Equity | $823,607 | $801,722 | $846,455 | $840,553 | $784,257 |